NIBEC Co., Ltd. Share Price

Equities

A138610

KR7138610001

Biotechnology & Medical Research

End-of-day quote Korea S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
17,190 KRW -0.64% Intraday chart for NIBEC Co., Ltd. +1.48% -20.60%

Financials

Sales 2022 21.67B 15.71M 1.31B Sales 2023 15.7B 11.39M 950M Capitalization 219B 159M 13.28B
Net income 2022 -3.77B -2.73M -228M Net income 2023 -6.28B -4.56M -380M EV / Sales 2022 8.06 x
Net cash position 2022 14.11B 10.23M 854M Net cash position 2023 5.06B 3.67M 306M EV / Sales 2023 13.7 x
P/E ratio 2022
-50 x
P/E ratio 2023
-
Employees 35
Yield 2022 *
-
Yield 2023
-
Free-Float 78.6%
More Fundamentals * Assessed data
Dynamic Chart
NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors CI
NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors CI
NIBEC Co., Ltd.(KOSDAQ:A138610) added to S&P Global BMI Index CI
NIBEC Co., Ltd. announced that it has received KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm CI
NIBEC Co., Ltd. announced that it expects to receive KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm CI
NIBEC Co., Ltd. announced that it has received KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd. CI
NIBEC Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd. CI
NIBEC Co. Ltd. announced that it has received KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors. CI
NIBEC Co. Ltd. announced that it expects to receive KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors. CI
NIBEC Co. Ltd. announced that it has received KRW 2 billion in funding. CI
NIBEC Co. Ltd. announced that it expects to receive KRW 2 billion in funding. CI
More news
1 day-0.64%
1 week+1.48%
Current month-7.58%
1 month-13.18%
3 months-2.05%
6 months+14.60%
Current year-20.60%
More quotes
1 week
17 130.00
Extreme 17130
17 750.00
1 month
16 650.00
Extreme 16650
20 500.00
Current year
16 290.00
Extreme 16290
25 750.00
1 year
11 430.00
Extreme 11430
25 900.00
3 years
11 430.00
Extreme 11430
55 500.00
5 years
4 800.00
Extreme 4800
55 500.00
10 years
3 950.00
Extreme 3950
55 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 78 -
Director/Board Member 49 -
Director/Board Member 53 -
Members of the board TitleAgeSince
Chief Executive Officer 78 -
Director/Board Member 53 -
Director/Board Member 49 -
More insiders
Date Price Change Volume
26/24/26 17,190 -0.64% 37,873
25/24/25 17,300 -1.93% 30,744
24/24/24 17,640 +0.74% 43,545
23/24/23 17,510 +0.34% 29,041
22/24/22 17,450 +3.01% 44,967

End-of-day quote Korea S.E., April 26, 2024

More quotes
NIBEC Co., Ltd. is a Korea-based company specialized in the manufacturing of dental medical products and supplies. The Company provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. It also provides cosmetics under the brand name Skin Aropa. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A138610 Stock